← All chemicals

CAS 149-30-4

2-Mercaptobenzothiazole

rubber acceleratorbiocideskin sensitizerHAP

2-Mercaptobenzothiazole is a rubber vulcanization accelerator that has been used in tires, gloves, and rubber goods for over a century — and is one of the most common causes of occupational and consumer contact allergy in the world.

Where It Comes From

2-Mercaptobenzothiazole (MBT) was first synthesized in 1893 and adopted as a vulcanization accelerator for rubber in the 1920s — the period when the synthetic rubber industry was building the foundations of modern tire manufacturing. [1] By accelerating the sulfur cross-linking reactions that give rubber its strength and elasticity, MBT dramatically reduced vulcanization times and improved product quality. It became ubiquitous in tires, industrial rubber goods, rubber gloves, shoes, gaskets, and adhesives. Beyond rubber, MBT is used as a biocide in industrial cooling water systems, metalworking fluids, and paper manufacture to prevent microbial growth. The compound's widespread presence in consumer goods led to its emergence as a major cause of allergic contact dermatitis — patch testing studies in Europe and North America consistently identified it as a common sensitizing agent, particularly from rubber gloves (including surgical and household gloves) and shoes. [2] The North American Contact Dermatitis Group (NACDG) has tracked it as one of the most prevalent contact allergens for decades. MBT is also an environmental contaminant — it leaches from rubber products, tires, and industrial systems into wastewater, where it has been detected in rivers, treated effluents, and even drinking water sources. [3] The EPA lists it as a Hazardous Air Pollutant and it is tracked under the TRI.

How You Are Exposed

Rubber industry workers (tire manufacturing, rubber goods production) have occupational inhalation and dermal exposure. Healthcare workers and home users wearing MBT-containing latex or synthetic rubber gloves absorb it through the skin. Shoe wearers absorb MBT through the soles of their feet from MBT-containing rubber shoe components. Metalworking fluid workers are exposed through skin contact and inhalation. Environmental exposures occur from contaminated water near rubber or metalworking facilities.

Why It Matters

MBT is a potent contact allergen — the key mechanism is haptenization of skin proteins, triggering T-cell-mediated delayed hypersensitivity (Type IV). Sensitized individuals develop dermatitis at the contact sites (hands from gloves, feet from shoes) with itching, redness, vesicles, and scaling. Sensitization is lifelong; even trace exposures in sensitized individuals can trigger reactions. [2] MBT also has aquatic toxicity, is moderately persistent in the environment, and has shown genotoxic activity in some in vitro assays, though it has not been classified as a carcinogen. Skin sensitization from occupational exposure can permanently affect ability to work in rubber or healthcare industries.

Who Is at Risk

Rubber manufacturing workers, healthcare workers wearing rubber gloves, construction workers using rubber adhesives and sealants, shoe factory workers, and metalworking fluid workers have the highest occupational exposures. Consumers who develop foot dermatitis from shoes or hand dermatitis from rubber gloves represent the largest sensitized population.

How to Lower Your Exposure

1. Switch to MBT-free alternatives: many manufacturers now produce MBT-free gloves (look for 'low-allergen' or 'thiuram-free and MBT-free' labels) and shoes (some manufacturers certify MBT-free construction). 2. Patch testing by a dermatologist can identify whether you are sensitized to MBT specifically. 3. Industrial rubber workers should use engineering controls and monitor for dermatitis symptoms. 4. In metalworking fluid systems, explore biocide alternatives with lower sensitization potential. 5. People with confirmed MBT allergy must strictly avoid rubber products containing it.

References

  1. [1][1] Rubber Chemistry and Technology, Historical Development of Vulcanization Accelerators. Rubber Division, ACS.
  2. [2][2] Warshaw EM, et al. (2010). Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data. Dermatitis, 21(6), 290–302.
  3. [3][3] Ni H-G, Lu S-Y, Zeng H (2008). Mercaptobenzothiazoles in urban runoff. Environmental Pollution, 156(3), 1113–1117.

Recovery & Clinical Information

Body Half-Life

MBT is absorbed through skin, metabolized in the liver (oxidation, conjugation), and excreted in urine partly as intact MBT-glucuronide and partly as benzothiazole and sulfate metabolites. Elimination half-life is estimated at 24–48 hours. With ongoing contact (e.g., wearing rubber gloves daily), low-level exposure continues. Once contact ceases, the compound clears within a few days.

Testing & Biomarkers

Urinary MBT and benzothiazole metabolites can be measured by HPLC-MS in research settings. Patch testing (not blood testing) is the gold standard for diagnosing MBT contact allergy — a positive patch test at 48 and 96 hours to the standard MBT patch test allergen (0.1% or 1% in petrolatum) confirms sensitization. No routine clinical blood test identifies sensitization.

Interventions

For sensitized individuals: strict avoidance of MBT-containing products is required — there is no desensitization for contact allergy. Active dermatitis is treated with topical corticosteroids (mild to moderate potency) and skin barrier restoration. Systemic corticosteroids for severe reactions. Barrier creams may reduce but cannot eliminate dermal exposure. For occupational exposure, product substitution is the most effective intervention.

Recovery Timeline

Acute allergic contact dermatitis episodes resolve within 1–3 weeks with treatment and avoidance of contact. However, sensitization is permanent — the next exposure will trigger a new reaction. The only long-term management strategy is complete avoidance of MBT in all products, which requires careful attention to product ingredient disclosures.

Recovery References

  1. [1]Bruze M, et al. (2005). Dermal absorption and excretion of mercaptobenzothiazole. Contact Dermatitis, 53(3), 134–139.
  2. [2]NACDG (2010). North American Contact Dermatitis Group Patch Test Results 2007–2008. Dermatitis, 21(6), 291–299.

Track your exposure to 2-Mercaptobenzothiazole

Pollution Profile maps your lifetime exposure history to EPA-tracked chemicals.

Get early access

We use cookies and analytics to understand how people use Pollution Profile and improve the experience. We never sell your data. Learn more.